Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial

Background Ketamine has recently become an agent of interest as an acute treatment for severe depression and as the anaesthetic for electroconvulsive therapy (ECT). Subanaesthetic doses result in an acute reduction in depression severity while evidence is equivocal for this antidepressant effect wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernie, Gordon, Currie, James, Perrin, Jennifer S., Stewart, Caroline A., Anderson, Virginica, Bennett, Daniel M., Hay, Steven, Reid, Ian C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of Psychiatrists 2017
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451642/
https://www.ncbi.nlm.nih.gov/pubmed/28254962
http://dx.doi.org/10.1192/bjp.bp.116.189134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451642/
https://www.ncbi.nlm.nih.gov/pubmed/28254962
http://dx.doi.org/10.1192/bjp.bp.116.189134

Ejemplares similares